IMAGINE IF! accelerator for life sciences and healthtech ventures

Past editions

The past editions of the IMAGINE IF! accelerator have built on the overarching role of the Innovation Forum in scouting and accelerating new technologies and startups from all over the world.

Every founder who has participated in the program is a key member of the Innovation Forum community and we are grateful to be part of their journey.

2021 global cohort:

Team [A-Z] Location
ABS Biotechnologies Vienna
Baby FM Belgrade
Bright Biotech Manchester
heecap Barcelona
Immtune Therapies London
INIA Biosciences USA
KoshKey Bengaluru
Limula Lausanne
MyLeg Zurich
Neobe Therapeutics London
OYS Mobility USA
Senior Deli Hong Kong
Verinnogen Cambridge


2019 global cohort:

Team [A-Z] Location
Aortyx Barcelona
ATCAE Mexico
Biel Barcelona
FluiDx Cambridge
Innaton Cyprus
Jelly Drops (winners) London
Lifespans Hong Kong
Neumind Oxford
Neurosoft Lausanne
NeutroCheck Cambridge
S-There Euskadi
Safe Cath London


2017 global cohort:

Team [A-Z] Location
AlgoSurg India
ART Research London
Àvida Biotech, S.L. Barcelona
BioMe (winners) Oxford
CamMat: Graphene Sensor Platforms Cambridge
CortiCare London
HyperC Oxford
Immaterial Cambridge
Komp-ACT Lausanne
Milkkit Manchester
MJN Neuroserveis Barcelona
Neo-Innovation UK Ltd London
NeuroDynamics Manchester
Sixfold Bioscience Cambridge
Skypull Lausanne
Spherox Pharmaceuticals Oxford
SunRegen Healthcare AG Lausanne
ThinAirWater Ltd London
Zaphiro Technologies Lausanne
Zunosaki Limited Hong Kong


2016 global cohort:

Team [A-Z] Location
AccuRx London
ATS Laboratory S.A. Krakow
CamSES Cambridge
CustoMem London
FlextraPower New York
GlykoGen Aberdeen
Lumigbo (formerly Taranutla) Lausanne
Lymphatica Lausanne
MeCURIS Munich
MedEXO Robotics Hong Kong
New Born Solutions Barcelona
NG:Safe Cambridge
Novus Life Sciences Hong Kong
RNAissance Therapeutics Cambridge
VisusNano Stevenage
We use cookies to ensure that we give you the best tailored experience on our website based on your preferences. By continuing to use our services, you are giving us your consent to use cookies. Learn more here.